Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients

NCT ID: NCT00543894

Last Updated: 2008-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection in ICU

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Antibiotic, ICU, hospital acquired infection.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay
* Hospital-acquired infections accounting for eligibility are:

* nosocomial pneumonia (including ventilator-associated pneumonia)
* bacteremia
* intra-abdominal infections
* urosepsis
Eligible Sex

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pr Vogelaers

Role: PRINCIPAL_INVESTIGATOR

UZ Gents

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SRP-HB-MER-2005/1

Identifier Type: -

Identifier Source: org_study_id